Chiara Vendramin

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

International Forum on the Management of Donors Following Recurrent Quality Monitoring System Failures and Subsequent Discards: Responses.

International Forum on the Management of Donors Following Recurrent Quality Monitoring System Failures and Subsequent Discards: Responses.

Journal: Vox sanguinis

Published: July 27, 2026

International Forum on the Management of Donors Following Recurrent Quality Monitoring System Failures and Subsequent Discards: Summary.

International Forum on the Management of Donors Following Recurrent Quality Monitoring System Failures and Subsequent Discards: Summary.

Journal: Vox sanguinis

Published: July 27, 2026

Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors.

Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors.

Journal: The Cochrane database of systematic reviews

Published: June 04, 2026

Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

Journal: Vox sanguinis

Published: February 07, 2026

Shrinking Weibel-Palade bodies prevents high platelet recruitment in assays using thrombotic thrombocytopenic purpura plasma.

Shrinking Weibel-Palade bodies prevents high platelet recruitment in assays using thrombotic thrombocytopenic purpura plasma.

Journal: Research and practice in thrombosis and haemostasis

Published: May 09, 2021

Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura.

Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura.

Journal: EJHaem

Published: February 07, 2021

von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome.

von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome.

Journal: Blood advances

Published: September 16, 2019

Indications of plasma exchanges in combination with intravenous immunoglobulins or therapeutic monoclonal antibodies. How to combine them?

Indications of plasma exchanges in combination with intravenous immunoglobulins or therapeutic monoclonal antibodies. How to combine them?

Journal: Presse medicale (Paris, France : 1983)

Published: July 05, 2019

Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remission.

Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remission.

Journal: British journal of haematology

Published: November 30, 2018

Characterization and treatment of congenital thrombotic thrombocytopenic purpura.

Characterization and treatment of congenital thrombotic thrombocytopenic purpura.

Journal: Blood

Published: November 07, 2018

Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura.

Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura.

Journal: Thrombosis and haemostasis

Published: September 21, 2018

Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura.

Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 21, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026